New combo aims to shield rheumatoid arthritis patients from heart attacks

This study looks at whether taking tofacitinib (a rheumatoid arthritis drug) along with a statin (a cholesterol-lowering drug) can lower the chance of serious heart problems in people with rheumatoid arthritis. The study will compare this combination to another standard treatment (TNF inhibitors). It involves 120 adults aged 50 or older who have moderate to severe rheumatoid arthritis and at least one heart disease risk factor, like high blood pressure or diabetes.